CD8A and nonpapillary renal cell carcinoma: As expected, the high levels of the CD8-C1 signature were associated with improved progression free survival (PFS) (Additional file 1: Fig. S2h), which was also supported by another study published recently that they observed a strong enrichment of the tissue resident CD8+ T cell cluster in one ccRCC patient with complete response to ICB [31].